PETER HENRY — Lobbyist Profile | Poliscope

PETER HENRY

Reported covered position: Leg Director, Sen. Dan Sullivan; Professional Staff Member, Senate Environment and Public Works Cmte; Sr Leg Assistant, Sen. Roy Blunt; Leg Assistant, Sen. Kit Bond; Leg Correspondent, Cong. Roy Blunt; Staff Assistant, Sen. Jim Talent

Filings

Clients

Firms

Years active

2024–2026

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
CLARITEV (FORMERLY MULTIPLAN CORPORATION)	11	2024–2026

Lobbying firms

Firm	Filings	Years
CLARITEV (FORMERLY MULTIPLAN CORPORATION)	11	2024–2026

Bills explicitly cited in this lobbyist’s assigned issues (8)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 5582

Patients Deserve Price Tags Act

Client: CLARITEV (FORMERLY MULTIPLAN CORPORATION) · Firm: CLARITEV (FORMERLY MULTIPLAN CORPORATION)

Open original LDA filing ↗

Cited source text

Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency

H.R. 5582

Patients Deserve Price Tags Act

Client: CLARITEV (FORMERLY MULTIPLAN CORPORATION) · Firm: CLARITEV (FORMERLY MULTIPLAN CORPORATION)

Open original LDA filing ↗

Cited source text

Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency

Original LDA source filings (11)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

CLARITEV (FORMERLY MULTIPLAN CORPORATION) via CLARITEV (FORMERLY MULTIPLAN CORPORATION)

2026 · third_quarter · Q3

Firm income: —Client expense: $100,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MMM

Medicare/Medicaid

Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and issues related to price and coverage transparency; Issues related to IDR portal and operations.

HCR

Health Issues

Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Source: Senate LDA

Show 7 more original filings

CLARITEV (FORMERLY MULTIPLAN CORPORATION) via CLARITEV (FORMERLY MULTIPLAN CORPORATION)

2025 · third_quarter · Q3

Firm income: —Client expense: $160,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355: Patients Deserve Price Tags Act including issues related to price and coverage transparency

MMM

Medicare/Medicaid

Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and issues related to price and coverage transparency

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

CLARITEV (FORMERLY MULTIPLAN CORPORATION) via CLARITEV (FORMERLY MULTIPLAN CORPORATION)

2025 · second_quarter · Q2

Firm income: —Client expense: $160,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and issues related to price and coverage transparency

MMM

Medicare/Medicaid

Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and issues related to price and coverage transparency

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

CLARITEV (FORMERLY MULTIPLAN CORPORATION) via CLARITEV (FORMERLY MULTIPLAN CORPORATION)

2025 · first_quarter · Q1

Firm income: —Client expense: $140,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and issues related to price and coverage transparency

Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

CLARITEV (FORMERLY MULTIPLAN CORPORATION) via CLARITEV (FORMERLY MULTIPLAN CORPORATION)

2024 · third_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues pertaining to payment for healthcare services.

CLARITEV (FORMERLY MULTIPLAN CORPORATION) via CLARITEV (FORMERLY MULTIPLAN CORPORATION)

2024 · third_quarter · 3A

Firm income: —Client expense: $110,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues pertaining to payment for healthcare services.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CLARITEV (FORMERLY MULTIPLAN CORPORATION) via CLARITEV (FORMERLY MULTIPLAN CORPORATION)

2024 · fourth_quarter · 4A

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues pertaining to payment for healthcare services.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CLARITEV (FORMERLY MULTIPLAN CORPORATION) via CLARITEV (FORMERLY MULTIPLAN CORPORATION)

2024 · third_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues pertaining to payment for healthcare services.